Company eFFECTOR Therapeutics, Inc. Deutsche Boerse AG
Equities
LWK1
US28202V1089
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.246 EUR | -77.12% | -8.12% | -88.97% |
06-24 | Sector Update: Health Care Stocks Rise in Late Afternoon Trading | MT |
06-24 | Top Midday Decliners | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Densel
PRN | Corporate Officer/Principal | - | 31/10/18 |
Mayank J. Gandhi
PRN | Corporate Officer/Principal | 47 | 25/09/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,716,409 | 4,567,493 ( 96.84 %) | 12,000 ( 0.2544 %) | 96.84 % |
Company contact information
eFFECTOR Therapeutics, Inc.
142 North Cedros Avenue Suite B
92075, Solana Beach
+
http://www.effector.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+22.18% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- EFTR Stock
- LWK1 Stock
- Company eFFECTOR Therapeutics, Inc.